by ARSACS | Feb 25, 2022 | Latest News
Thank you if you have completed already the PROSPAX survey #2. We still need a greater representation of people with ARSACS for the research. Therefore, the deadline has been extended to Sunday March 6. Please take few minutes to provide your insight so people with...
by ARSACS | Feb 22, 2022 | Latest News
by ARSACS | Feb 16, 2022 | Latest News
Brief summary of the results of Dr. Maltecca’s research project “Targeting deregulated calcium homeostasis as potential therapeutic option for ARSACS”. The results indicate that targeting calcium may represent a therapeutic option for ARSACS.
by ARSACS | Feb 3, 2022 | Latest News
Make your voice heard. Let researchers know what is important to you and how you feel living with the condition.You do not need to have completed the first survey to fill out this survey. A parent of a child can fill out the survey. PROSPAX is a 3 year...
by ARSACS | Feb 1, 2022 | Latest News
If you are interested in joining the team of researchers around the world to advance the understanding of ARSACS and lead to a treatment, please send us your proposal. For details : Financing Offer and ARSACS Appendix. Deadline : May 27, 2022.
by ARSACS | Jan 25, 2022 | Latest News
ARSACS research conducted by Dr. Federico Herrera and his team in Portugal,“Sacsin Deletion Induces Aggregation of Glial Intermediate Filaments” , published in the Cells Journal on January 16, 2022.
by ARSACS | Jan 21, 2022 | Latest News
ARSACS research project, led by Drs. Mckinney ,Watt and Toscano- Marquez, was featured on CBC radio “Let’s Go” on 2022-01-20. As part of the “Understanding the Brain” segment, Rackeb Tesfaye, science columnist at CBC radio and a PHD...
by ARSACS | Jan 2, 2022 | Latest News
” To all of you : Mr. Marc Bédard, Honorary President, sponsors, partners, donors and volunteers, it is thanks to you that the Foundation can pursue it’s mission. Thank you! ” Jean Groleau , president of the Ataxia Charlevoix-Saguenay Foundation. The Diner des...
by ARSACS | Dec 22, 2021 | Latest News
Latest news release from McGill University, Montreal- Researchers at McGill University, lead by Drs. Alanna Watt and Anne Mckinney, have made an important step forward in understanding the cause of ARSACS. “We have shown really clearly that zebrin-negative cells in...
by ARSACS | Dec 21, 2021 | Latest News
The Ataxia Charlevoix-Saguenay Foundation is pleased to announce that Dr. Massimo Pandolfo has joined its board of directors. Dr. Pandolfo is Professor of Neurology at McGill University in Montreal since January 2021. Prior, he was Professor of neurology and Director...
by ARSACS | Dec 18, 2021 | Latest News
Research of Drs. Nethisinghe and Giunti, “Hsp90 Inhibition: A Promising Therapeutic Approach for ARSACS”, was published in the International Journal of Molecular Sciences in October 2021. This research was made possible thanks to the Foundation in...
by ARSACS | Dec 16, 2021 | Latest News
Me Jean Groleau, co-founder and president of the Fondation de l’Ataxie Charlevoix-Saguenay, is proud to join Catalis to represent the needs and challenges of people with rare diseases. Launched in 2017, CATALIS’ mandate is, among other things, to...
by ARSACS | Dec 7, 2021 | Latest News
The Foundation’s fundraising campaign is underway until the end of December. We need your support to pursue our mission to finance ARSACS research. Together we can work toward the goal of making lives better for individuals affected by ARSACS. Research needs...
by ARSACS | Dec 6, 2021 | Latest News, Past Conferences
More than 200 participants from different backgrounds (academic, pharmaceutical and people with ARSACS) participated in the Symposium. An international network of ARSACS researchers who shared their research progress in a climate of collaboration and exchange of...
by ARSACS | Nov 29, 2021 | Latest News
The Organizzazione di volontariato (ODV) is offering a seed grant of 50 000€ to finance research on ARSACS in partnership with the Fondazione Telethon . This opportunity is for researchers in Italy. However, a project involving an international collaboration would...
by ARSACS | Nov 18, 2021 | Latest News
The research by Drs Alanna Watt and Anne Mckinney “Molecular identity and location influence Purkinje cell vulnerability in ARSACS mice” has been published in the Frontiers Journal. At this time, only the abstract is available. The manuscript will be on...
by ARSACS | Oct 31, 2021 | Latest News
The Foundation is pleased to announce that 9 research projects will be funded for a total of $735,000 in order to continue ARSACS research. The projects were selected based on their scientific value. It is very encouraging to see the collaboration and the sharing of...
by ARSACS | Oct 28, 2021 | Latest News
The Ataxia Charlevoix-Saguenay Foundation cordially invites you to its annual fundraising “Le Diner des Producteurs” under the honorary presidency of Mr. Marc Bédard, President and founder of Lion Électrique. Reserve now.
by ARSACS | Oct 21, 2021 | Latest News
Research done by Dr C. Gagnon and her team published in Orphanet Journal of Rare Diseases. “Functional mobility in walking adult population with ataxia Charlevoix-Saguenay”, the first study to focus on adult walkers with ARSACS, was funded in part by the...
by ARSACS | Oct 16, 2021 | Latest News
The research, funded by the Foundation and entitled “Assessment of sacsin turnover in ARSACS patients: implications for molecular diagnosis and pathogenesis”, has been done by Fabiana Longo and the group headed by Francesca Maltecca at Ospedale San Raffaele,...
